Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
234.40
-1.64 (-0.69%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25,872 | 19,304 | 16,838 | 15,503 | 17,817 | 21,224 | |
Market Cap Growth | 29.22% | 14.64% | 8.62% | -12.99% | -16.05% | 32.15% |
Enterprise Value | 31,650 | 25,369 | 23,156 | 20,386 | 21,871 | 25,006 |
Last Close Price | 234.40 | 171.29 | 146.15 | 130.77 | 145.38 | 157.67 |
PE Ratio | 24.89 | 19.54 | 19.44 | 18.24 | 18.91 | 10.68 |
Forward PE | 20.46 | 17.07 | 15.97 | 15.53 | 18.91 | 18.61 |
PS Ratio | 2.24 | 1.75 | 1.71 | 1.68 | 1.80 | 1.97 |
PB Ratio | 3.43 | 2.65 | 2.44 | 2.42 | 2.97 | 3.23 |
P/FCF Ratio | 19.18 | 14.20 | 18.52 | 17.94 | 13.56 | 11.60 |
P/OCF Ratio | 13.60 | 10.24 | 12.62 | 12.19 | 10.37 | 9.51 |
PEG Ratio | 2.16 | 2.04 | 2.42 | 13.49 | 13.49 | 13.49 |
EV/Sales Ratio | 2.74 | 2.30 | 2.35 | 2.20 | 2.21 | 2.32 |
EV/EBITDA Ratio | 13.97 | 11.66 | 12.14 | 11.62 | 11.31 | 8.93 |
EV/EBIT Ratio | 18.77 | 15.81 | 16.38 | 15.49 | 14.61 | 10.45 |
EV/FCF Ratio | 23.46 | 18.67 | 25.47 | 23.59 | 16.64 | 13.66 |
Debt / Equity Ratio | 0.81 | 0.90 | 1.03 | 0.86 | 0.79 | 0.73 |
Debt / EBITDA Ratio | 2.31 | 2.49 | 3.08 | 2.61 | 2.07 | 1.53 |
Debt / FCF Ratio | 4.75 | 4.85 | 7.83 | 6.36 | 3.59 | 2.61 |
Net Debt / Equity Ratio | 0.73 | 0.85 | 0.95 | 0.75 | 0.73 | 0.59 |
Net Debt / EBITDA Ratio | 2.55 | 2.83 | 3.45 | 2.74 | 2.28 | 1.38 |
Net Debt / FCF Ratio | 4.28 | 4.54 | 7.23 | 5.57 | 3.35 | 2.11 |
Asset Turnover | 0.70 | 0.68 | 0.65 | 0.69 | 0.75 | 0.78 |
Inventory Turnover | 36.78 | 39.03 | 34.92 | 32.39 | 32.16 | 30.49 |
Quick Ratio | 1.28 | 0.80 | 0.85 | 1.05 | 0.97 | 1.34 |
Current Ratio | 1.59 | 1.04 | 1.10 | 1.31 | 1.22 | 1.56 |
Return on Equity (ROE) | 14.60% | 14.75% | 13.84% | 14.62% | 16.15% | 30.92% |
Return on Assets (ROA) | 6.40% | 6.20% | 5.86% | 6.13% | 7.07% | 10.82% |
Return on Invested Capital (ROIC) | 9.54% | 9.17% | 8.83% | 9.55% | 11.41% | 17.74% |
Return on Capital Employed (ROCE) | 11.10% | 11.50% | 10.10% | 10.80% | 13.30% | 20.20% |
Earnings Yield | 4.09% | 5.14% | 5.17% | 5.51% | 5.31% | 9.40% |
FCF Yield | 5.21% | 7.04% | 5.40% | 5.57% | 7.38% | 8.62% |
Dividend Yield | 1.47% | 1.87% | 2.05% | 2.17% | 1.82% | 1.57% |
Payout Ratio | 36.53% | 35.59% | 38.00% | 36.77% | 32.24% | 15.49% |
Buyback Yield / Dilution | 0.88% | - | 0.89% | 4.24% | 7.81% | 5.88% |
Total Shareholder Return | 2.35% | 1.87% | 2.95% | 6.41% | 9.63% | 7.46% |